Our data shows the critical role which the chemokine CXCL1 plays in cisplatin-induced kidney inflammation, while also providing an opportunity for the evaluation of therapeutic interventions based on this, and other inflammatory biomarkers, in AKI. This evidence concerns the gene CXCL1 and nephritis.